Curative Biosciences Net income (Q3, 2018)-32 K
Curative Biosciences EBIT (Q3, 2018)-32 K
Curative Biosciences Cash, 31-Mar-2018982

Curative Biosciences Income Statement

Annual

USDFY, 2014FY, 2015FY, 2016FY, 2017

General and administrative expense

518.4k1.7m1.6m53.2k

Operating expense total

518.4k(3.4m)1.7m53.2k

EBIT

(29.9m)3.4m(1.7m)(53.2k)

Net Income

(29.9m)(3.4m)(1.7m)(53.2k)

Quarterly

USDQ1, 2014Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

General and administrative expense

86.3k87.1k1.5m489.5k1.1m5.3k24.5k6.8k4.0k16.7k26.2k32.0k

Operating expense total

58.6k87.1k1.5m489.5k1.1m5.3k24.5k6.8k4.0k16.7k451.5k32.0k

EBIT

(86.3k)(87.1k)(2.9m)(505.6k)(1.1m)(5.3k)(24.5k)6.8k4.0k(16.7k)451.5k(32.0k)

Net Income

(86.3k)(87.1k)(2.9m)(505.6k)(1.1m)(5.3k)(24.5k)6.8k4.0k(16.7k)451.5k(32.0k)

Curative Biosciences Balance Sheet

Annual

USDFY, 2014FY, 2015FY, 2016FY, 2017

Cash

1.8k2.0k

Current Assets

3.6k2.0k

Total Assets

15.7k10.0k5.1k2.3k

Accounts Payable

88.5k123.5k160.8k177.4k

Current Liabilities

249.2k705.8k620.2k633.1k

Total Liabilities

705.8k620.2k633.1k

Additional Paid-in Capital

47.8m50.7m52.5m52.5m

Total Equity

(233.6k)(695.8k)(615.1k)(630.8k)

Financial Leverage

-0.1 x0 x0 x0 x

Quarterly

USDQ2, 2014Q1, 2014Q2, 2015Q3, 2015Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Cash

1.8k1.8k1.8k1.8k2.0k982.0

Inventories

51.0k45.9k

Current Assets

64.0k49.5k3.6k3.6k2.0k982.0

Total Assets

83.6k66.6k13.0k12.3k8.5k5.8k4.4k3.7k3.0k1.6k841.013.9k

Accounts Payable

88.5k88.5k98.4k98.4k131.4k128.9k158.9k160.6k161.9k175.7k170.2k170.2k

Current Liabilities

92.1k129.1k480.2k569.2k572.5k575.1k606.5k612.6k615.9k649.1k674.5k719.5k

Total Liabilities

129.1k572.5k575.1k606.5k612.6k615.9k649.1k674.5k719.5k

Additional Paid-in Capital

47.7m47.7m47.8m50.6m52.5m52.5m52.5m52.5m52.5m52.5m52.9m52.9m

Retained Earnings

(47.7m)

Total Equity

(6.0k)(62.6k)(467.2k)(556.9k)(563.9k)(569.3k)(602.1k)(608.9k)(612.9k)(647.5k)(673.7k)(705.7k)

Financial Leverage

-14 x-1.1 x0 x0 x0 x0 x0 x0 x0 x0 x0 x0 x

Curative Biosciences Cash Flow

Annual

USDFY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(29.9m)(3.4m)(1.7m)(53.2k)

Depreciation and Amortization

2.9k2.8k2.8k2.8k

Inventories

51.0k

Accounts Payable

79.8k

Cash From Operating Activities

(65.3k)

Cash From Financing Activities

144.3k65.5k27.0k12.8k

Quarterly

USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q3, 2018

Net Income

(58.6k)(87.1k)(2.9m)(505.6k)(1.1m)(1.6m)(24.5k)(31.3k)(35.3k)(500.2k)

Depreciation and Amortization

2.1k712.01.4k2.1k1.9k

Accounts Payable

98.4k98.4k127.8k131.4k(1.9k)(236.0)1.1k

Cash From Investing Activities

(12.5k)

Cash From Financing Activities

20.5k4.7k9.1k11.1k93.6k
Report incorrect company information